Two case reports of continued progression of chronic ocular graft-versus-host disease without concurrent systemic comorbidities treated by amniotic membrane transplantation.
Hideto IkarashiNaohiko AketaEisuke ShimizuYoji TakanoTetsuya KawakitaYuichi UchinoYukihiro MatsumotoJunko OgawaKazuo TsubotaYoko OgawaPublished in: BMC ophthalmology (2021)
We reported the clinical outcomes of 2 cases of chronic oGVHD without concurrent systemic comorbidities that were treated with AMT. The clinician should be aware that cGVHD may persist in target organs even in the absence of concurrent systemic comorbidities following seemingly successful systemic treatment. A multidisciplinary team approach is essential in the early detection and therapeutic intervention for chronic oGVHD.